苏州工业园区发布“生物医药及大健康产业腾飞计划”

Core Insights - The "Suzhou Industrial Park Accelerates the Action Plan for the Biopharmaceutical and Health Industry (2025-2027)" was officially released, focusing on key areas such as innovative drugs, high-end medical devices, and health care [1][2] - The plan aims to support the scaled development of enterprises, the landing of quality incremental projects, the launch of innovative products, and the promotion of their application [1][4] Group 1: Enterprise Development - The park will focus on nurturing strong enterprises by supporting increased fixed asset investment, expanding enterprise scale, boosting revenue, and enhancing R&D investment [1] - There will be a focus on attracting world-class companies, including Fortune 500 and top Chinese pharmaceutical companies, to support the localization of quality product pipelines and contract development manufacturing organizations (CDMO) [1][2] Group 2: Product Support and Promotion - The plan includes support for the listing of significant products, dynamic selection of key product pipelines, and enhancement of clinical trial capabilities in medical institutions [2] - It will also promote the use of innovative drugs and devices in medical institutions and encourage participation in centralized procurement to expand sales [2] Group 3: Financing and Investment - The park will enhance equity financing support through cornerstone investments and long-term holdings, aiming for over 5 billion yuan in investments in park enterprises over the next three years [3] - There will be an increase in credit financing, with commercial banks encouraged to provide medium- and long-term credit products [3] Group 4: Innovation and Regulatory Support - The plan aims to address development bottlenecks through institutional innovation, leveraging advantages from international cooperation and free trade zones [4] - It includes initiatives to shorten review and approval times for clinical trials and support global leading food and health products in compliance with regulations [4] Group 5: Future Goals - By 2027, the park aims to cultivate over 5 leading enterprises with international competitiveness, over 50 landmark enterprises, and achieve significant sales milestones for key products [4]